Current visiting times

After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”

Read more on visiting times...


Messages for loved ones and keeping in touch

We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication.  Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.

Read more information about messages for loved ones…

Current visiting times

After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”

Read more on visiting times...


Messages for loved ones and keeping in touch

We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication.  Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.

Read more information about messages for loved ones…

During your stay in hospital you will meet a number of different members of staff.  All members of staff wear name badges, but if you are not sure who someone is or what they do, please feel free to ask them to introduce themselves and explain what they do. 

If you have any questions about your treatment, please ask a doctor or a nurse.

There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.

Staff spotlight

Last updated: 21 October 2021

To celebrate research undertaken by our research staff here at PHU, the research and innovation team brings you 'Spotlight'.

We will be highlighting members of our team and putting a spotlight on their achievements and current research including any recent publications.

 

  

Having recently been nominated for, and winning PHU’s junior doctor award for his outstanding contribution to education, research, and improvement, it’s been a whirlwind year for Dr Ben Giles, who joined the Hepatology Department as a clinical research fellow in August 2020.

Increasing rates of liver-related deaths in the UK, a lack of effective treatments in many areas of hepatology, as well as an interest in the specialty, first led to Ben getting involved in hepatology research:

“By gaining this invaluable experience I have been able to see first-hand the direct correlation between research and the positive impact it can have on treatments and patient outcomes.”

Despite the disruptions caused by the pandemic, Ben set up the UK's first national registry for people with Polycystic Liver Disease (PLD) which is currently being expanded to other sites across the UK. Ben’s work has also culminated in PHU becoming the first centre in the UK to complete data collection of over 100 patients in a national Primary Biliary Cholangitis (PBC) audit. In addition, he carried out a controlled evaluation of the impact of the Portsmouth Liver Centre’s nurse-led decompensated cirrhosis service on patient outcomes. This highlighted the huge impact this service has in reducing unplanned hospital re-admissions and deaths in this high-risk patient group.

Over the past year, Ben has conducted a five-year review to evaluate ‘aMAP’, a scoring system to help predict hepatocellular carcinoma (HCC) for patients with cirrhosis - a leading cause of death in patients with chronic viral hepatitis and globally, the fourth most frequent cause of cancer-related death. Ben's study was the first evaluation of aMAP in an unselected UK population, and demonstrated that HCC patients have a "high risk" score up to five years before their presentation with cancer and was recently presented at the national UK-HCC conference.  By identifying this risk in the early stages will potentially allow more focused surveillance of patients at higher risk.

During the second wave of Covid-19, Ben made an enormous contribution to the delivery of urgent Covid-19 therapy trials here in Portsmouth. He also worked on a project looking at the differences in severity of disease in patients with the B.1.1.7 (alpha or ‘Kent’) Covid-19 variant which was recently published.

“It is incredibly rewarding to see how research and collation of data can lead to successfully identifying new treatments for patients. It was a real honour recently to be involved with a particular patient’s discharge from hospital who had Covid-19. Had it not been for her receiving a new treatment for Covid-19 that we researched as part of the Recovery trial here in Portsmouth, she may have required admission to the intensive care unit and quite possibly have died.”

Ben’s links:

Publications: The SARS-CoV-2 B.1.1.7 variant and increased clinical severity-the jury is out.
Twitter: @BenGiles146

I am starting the fourth year of my part-time PHD at the University of Portsmouth and also work as a senior cardiac physiologist at Portsmouth Hospitals University NHS Trust (PHU).

My PHD study is called GLASSheart and is investigating heart function by using non-standard echocardiography (echo) and blood results in patients who have been admitted with sepsis or septic shock to the intensive care unit (ICU) at Queen Alexandra Hospital in Cosham. Patients participating in the study have an echo and bloods done on admission, and during their three-month follow-up. My study sits within the National Institute of Health’s research portfolio.

Although significantly delayed due to covid, it has been fantastic to start meeting and recruiting patients and follow them along the GLASSheart journey. Seeing patients progress from being seriously ill in ICU, to walking through my clinic door with a smile, may well be the best part of research! Working with the research staff at PHU has been incredibly rewarding and I’m not sure how I could have done it without their support.

Research patient, Phil Gibbs from Waterlooville, is involved in the study and said: “Getting involved in research is one way I can help the NHS. Research is so vital for us to gain a better understanding of medical conditions. We always need to keep finding out and discovering new treatments.

“By taking part in the GLASSheart study, I hope I can help clinicians gain a further understanding of sepsis in the heart and its impact on patients and their quality of life. I would recommend anyone who is able to, to get involved in research.”

On what will make the study a success, Emma said that identifying heart failure early in sepsis and septic shock could help clinicians consider alternative treatments for patients. This study lays the foundation of knowledge, it doesn’t look to change the treatments. The legacy of sepsis and septic shock on heart function is currently unknown, however the GLASSheart study could help identify how patients could benefit from post-discharge cardiac involvement and if early involvement might help improve their quality of life.

She added, “I am excited to see the results of my GLASSheart study and how it could improve patient outcomes. A multi-centre study in the future could help build on findings, and something that I would love to be involved in! It would be great to see a wider range of clinical staff getting involved in research and I would love to include research as part of my future role after completing my PhD.”

Thank you to Ambu ECG electrodes and Cardiac Remotes Ltd who have kindly supported and funded the additional research costs.

How to contact Emma:
email:
glassheart.study@porthosp.nhs.uk
Twitter
: @em_echo

To find out more about other clinical academics here at PHU please click here: https://www.porthosp.nhs.uk/research/clinical-academic-hub.htm and follow us on twitter @CAhubPHU

Back to top
Working together to drive excellence in care for our patients and communities Page feedback Tell us what you think

Get in touch

Queen Alexandra Hospital,
Cosham,
Portsmouth,
PO6 3LY

© 2021, Portsmouth Hospitals NHS Trust